Timothy Carll

560 total citations
25 papers, 361 citations indexed

About

Timothy Carll is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Timothy Carll has authored 25 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Timothy Carll's work include Blood transfusion and management (5 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (5 papers) and Immunotherapy and Immune Responses (5 papers). Timothy Carll is often cited by papers focused on Blood transfusion and management (5 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (5 papers) and Immunotherapy and Immune Responses (5 papers). Timothy Carll collaborates with scholars based in United States, Canada and United Kingdom. Timothy Carll's co-authors include Geoffrey D. Wool, Yuanyuan Zha, Jason J. Luke, Daniel J. Olson, Brian Labadie, Riyue Bao, Zeynep Eroglu, Madhuri Bajaj, Sigrun Hallmeyer and Thomas Krausz and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Timothy Carll

20 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Carll United States 10 174 104 82 49 45 25 361
Eren Gündüz Türkiye 11 33 0.2× 32 0.3× 43 0.5× 172 3.5× 25 0.6× 62 326
Yingping Cao China 9 129 0.7× 51 0.5× 64 0.8× 15 0.3× 36 0.8× 23 267
Shikai Geng China 10 43 0.2× 102 1.0× 118 1.4× 22 0.4× 34 0.8× 15 345
Edwin A. Burgstaler United States 14 80 0.5× 105 1.0× 54 0.7× 313 6.4× 40 0.9× 43 548
Ryan A. Metcalf United States 12 72 0.4× 25 0.2× 75 0.9× 93 1.9× 60 1.3× 44 460
Katsutoshi Ando Japan 13 152 0.9× 61 0.6× 112 1.4× 13 0.3× 65 1.4× 41 685
Marshall Mazepa United States 11 44 0.3× 123 1.2× 56 0.7× 296 6.0× 20 0.4× 33 449
Ankit Mangla United States 10 156 0.9× 37 0.4× 41 0.5× 39 0.8× 63 1.4× 74 332
Turgut Kaçan Türkiye 12 152 0.9× 32 0.3× 61 0.7× 10 0.2× 49 1.1× 42 354
Sandip H. Patel United States 10 487 2.8× 91 0.9× 79 1.0× 20 0.4× 59 1.3× 31 611

Countries citing papers authored by Timothy Carll

Since Specialization
Citations

This map shows the geographic impact of Timothy Carll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Carll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Carll more than expected).

Fields of papers citing papers by Timothy Carll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Carll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Carll. The network helps show where Timothy Carll may publish in the future.

Co-authorship network of co-authors of Timothy Carll

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Carll. A scholar is included among the top collaborators of Timothy Carll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Carll. Timothy Carll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carll, Timothy, et al.. (2025). Citrate & Hypocalcemia in Massive Transfusion. Medical Research Archives. 13(8).
2.
Carll, Timothy, et al.. (2024). Transfusion management and hemoglobin‐based oxygen carrier treatment in a patient with anti‐Rh17 antibody. Transfusion. 64(6). 1161–1166. 1 indexed citations
3.
Carll, Timothy, et al.. (2024). Determination of Citrate Content of Commonly Transfused Blood Products. American Journal of Clinical Pathology. 162(Supplement_1). S176–S176.
4.
5.
Carll, Timothy, et al.. (2023). Sensitivity and specificity of thromboelastography for hyperfibrinolysis: Comparison of TEG 5000 and TEG 6S CK LY30 systems. American Journal of Clinical Pathology. 160(5). 455–465. 1 indexed citations
6.
Carll, Timothy. (2023). Viscoelastic Testing Methods. Advances in clinical chemistry. 117. 1–52. 3 indexed citations
7.
Wool, Geoffrey D. & Timothy Carll. (2023). Viscoelastic testing: Critical appraisal of new methodologies and current literature. International Journal of Laboratory Hematology. 45(5). 643–658. 9 indexed citations
8.
9.
Carll, Timothy, et al.. (2022). Tissue Contamination During Transportation of Formalin-Fixed, Paraffin-Embedded Blocks. American Journal of Clinical Pathology. 158(1). 96–104. 6 indexed citations
10.
Olson, Daniel J., Zeynep Eroglu, Bruce Brockstein, et al.. (2021). Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma. Journal of Clinical Oncology. 39(24). 2647–2655. 136 indexed citations
11.
Yu, Jovian, Brian C.‐H. Chiu, Timothy Carll, et al.. (2021). Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators. Haematologica. 107(4). 966–969. 3 indexed citations
12.
Carll, Timothy & Geoffrey D. Wool. (2020). Basic principles of viscoelastic testing. Transfusion. 60(S6). S1–S9. 51 indexed citations
13.
Bao, Riyue, Oliver Surriga, Daniel J. Olson, et al.. (2020). Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target. Melanoma Research. 31(1). 27–37. 11 indexed citations
14.
Luke, Jason J., Daniel J. Olson, Jacob B. Allred, et al.. (2019). Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201). Clinical Cancer Research. 26(4). 804–811. 43 indexed citations
15.
Luke, Jason J., Sandeep R. Bhave, Theodore Karrison, et al.. (2019). Multi-Site SBRT and Sequential Pembrolizumab: Treated Metastasis Control and Immune-Related Expression Predict Outcomes. International Journal of Radiation Oncology*Biology*Physics. 104(5). 1190–1191. 5 indexed citations
16.
Carll, Timothy & Geoffrey D. Wool. (2019). A Laboratory Investigation in Response to Clinical Concern Regarding Heparin-PF4 ELISA Accuracy. American Journal of Clinical Pathology. 152(Supplement_1). S22–S22.
17.
Carll, Timothy, et al.. (2019). Evaluation of the Clinical Utility of Factor V, VII, and VIII Assays in Assessment of DIC. American Journal of Clinical Pathology. 152(Supplement_1). S22–S23.
18.
Lee, Daniel J., et al.. (2019). Assessment of Consistency Between Peer-Reviewed Publications and Clinical Trial Registries. JAMA Ophthalmology. 137(5). 552–552. 11 indexed citations
19.
Ginat, Daniel Thomas, Timothy Carll, & Fuad M. Baroody. (2018). Heterotopic Gastrointestinal Cyst of the Oral Cavity Radiology–Pathology Correlation. Head and Neck Pathology. 13(4). 668–670. 6 indexed citations
20.
Olson, Daniel J., Jason J. Luke, Sigrun Hallmeyer, et al.. (2018). Phase II trial of pembrolizumab (pembro) plus 1 mg/kg ipilimumab (ipi) immediately following progression on anti-PD-1 Ab in melanoma (mel).. Journal of Clinical Oncology. 36(15_suppl). 9514–9514. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eren Gündüz Breakdown of academic impact, for papers by Yingping Cao Breakdown of academic impact, for papers by Shikai Geng Breakdown of academic impact, for papers by Edwin A. Burgstaler Breakdown of academic impact, for papers by Ryan A. Metcalf Breakdown of academic impact, for papers by Katsutoshi Ando Breakdown of academic impact, for papers by Marshall Mazepa Breakdown of academic impact, for papers by Ankit Mangla Breakdown of academic impact, for papers by Turgut Kaçan Breakdown of academic impact, for papers by Sandip H. Patel
Rankless by CCL
2026